This via the excellent Internet Drug News:
Shares of Sanofi-Aventis and Bristol-Myers Squibb Co. slumped on speculation that a generic version of their top-selling Plavix blood thinner may become available within weeks.
David Snow, chief executive officer of U.S. drug distributor Medco Health Solutions Inc., said today that he expected a generic as soon as this month. Plavix was the world's second best-selling medicine last year, bringing in $6.3 billion for Paris-based Sanofi and New York-based Bristol-Myers.
Medco's prediction arose from "market chatter,'' Medco Chief Financial Officer Joann Reed said.
Apotex Inc., of Weston, Ontario, has U.S. approval to sell a copy, although Sanofi and Bristol-Myers agreed in March to pay Apotex at least $40 million to keep the generic off the market until 2011.
The U.S. Federal Trade Commission is still reviewing the agreement, and state attorneys general have objected to it.
More.
No comments:
Post a Comment